Kaiser Family Foundation releases primer on U.S. engagement in global health issues

A new Kaiser Family Foundation primer "provides a comprehensive overview of the U.S. government's engagement in global health issues, including a look at the federal programs that support these efforts," according to an email alert from the foundation. "The 'U.S. Government Engagement In Global Health: A Primer' provides basic information about global health challenges and a brief history of the evolving response from the U.S. government and the world"; "describes the U.S. agencies and programs involved in global health and the federal budget supporting these efforts, including regional and country breakouts"; and "explores how the U.S. engages with multilateral organizations, such as the World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria," the alert states (2/1).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spermidine regulates RIPK1 to combat diabetes and vascular damage